GlyCLAZIDE MV

ʻO Glyclazide MB kahi mākaukau waha hypoglycemic pili i ka derogatives sulfonylurea o ka hanauna 2. ʻO ka lāʻau lapaʻau:

1. hoʻoikaika i ka hana o ka insulin hormone,
2. hoʻonui i ka hopena o ka insulin-secretory o ka glucose,
3. hoʻohaʻahaʻa i ke kō
4. hoʻonui i ka hoʻoliʻi ʻana o ka insulin i nā kiko peripheral.,
5. ka hoʻoikaika ʻana i ka pae o ka wikiwiki o ka maʻi glycemia,
6. hōʻemi i ka hana glucose ate,
7. i ka hoʻohui ʻana i ka hana o ka mea laita, hoʻolaʻa ka lāʻau i ka microcirculation.

Hoʻopau ʻo Glyclazide i ka nui o ke kuʻi koko i loko o nā moku liʻiliʻi, e hoʻopiʻi i ka manawa like i ʻelua mau ʻano hana i pili i ka hoʻomohala ʻana o nā hoʻopiʻi o ka maʻi mellitus:

• hoʻokaʻawale wahi o ka platelet adhesion a me ka hoʻopili ʻana,
• no ka hoʻōla
• e hōʻemi i nā mea kaha o ka platelet (thromboxane B_2, beta thromboglobulin).

Nā Hoʻohui

• maʻi diabetes type 1
• ka manaʻo kiʻekiʻe ma Glyclazide a i nā māhele o ka lāʻau lapaʻau (i ka sulfonamides, i nā derivatives sulfonylurea),
• hapai a lactation
• huʻi a palu wale paha ʻole,
• lawe ʻia
• coma maʻi maʻi
• precoma maʻiʻaʻai
• maʻi maʻamau ketoacidosis,
• makahiki i 18 makahiki
• lactase hemahema
• paulele lactose intolerance,
• ʻAʻoleʻike nā kauka i ka hoʻohana like ʻana o ka lāʻau i ka hui pū ʻana me danazol a i ʻole phenylbutazone.

I ka wa e lawe ʻia me ka mālama

ʻAʻole hiki ke hoʻohana ʻia ʻo Gliclazide me ka loaʻa ʻole o ka lāʻau lapaʻau, ʻoiai ʻaʻole kūpono nā lāʻau lapaʻau i nā mea a pau. Eia ka papa inoa o nā kūlana e pono ai e hoʻohana me ka akahele:

1. ke kūlike ʻole a i ʻole nā ​​hoʻoponopono kūpono ʻole;
2. hiʻona kiʻekiʻe
3. hypothyroidism
4. kakaha hipokoke a adrenal paha,
5. nā maʻi koʻikoʻi o ka ʻōnaehana cardiovascular (atherosclerosis, maʻi maʻi coronary),
6. hipapoliona,
7. hana hoʻolauleʻa glucocorticosteroid lōʻihi,
8. puʻuwai a palau paha,
9. Iʻa nele o ka glucose-6-phosphate dehydrogenase,
10. waiʻona.

E makaʻala! Ke kuhikuhi ʻia nei ka lāʻau lapaʻau wale nō no nā pākeke!

Pehea e mālama ai i ka wā hāpai a me ka umauma

ʻAʻohe ʻikepili i ka hoʻohana ʻana i ka lāʻau lapaʻau i ka wā o ka maʻi. Loaʻa ka ʻikepili e pili ana i ka hoʻohana ʻana o nā kumulā sulfonylurea i ka wā hapai.

Ma nā noiʻi noiʻi e pili ana i nā holoholona, ​​ʻaʻole i ʻike ʻia nā hopena teratogenic o ka lāʻau. No ka hōʻemi i ka hopena o ka malenations ma ka hopena, pono ʻoe i ka kaohi o ka maʻi mellitus o ka maʻi mellitus (ʻoi aku ka lapaʻau).

Nui! ʻAʻole i kuhikuhi ʻia nā lāʻau waha he hypoglycemic i ka wā hāpai. No ka mālamaʻana i ka maʻi maʻi i ka wā hāpai, koho ʻia ka insulin lapaʻau. Hoʻomaopopo ʻia ka loaʻa ʻana o nā lāʻau lapa hypoglycemic ke hoʻohuli ʻia e ka maʻi insulin.

Eia kekahi, pili kēia kānāwai i ka hihia i ka wā e hāpai ai ka wahine i ka manawa e lawe ai i ka lāʻau lapaʻau, a inā komo wale nō ka hapai i nā hoʻolālā o ka wahine.

Hāʻawi ʻia i ka ʻike ʻole o ka ʻikepili i ka intake o ka lāʻau i ka waiū umauma, ʻaʻole i haʻalele ʻia ka hopena o ka hoʻoulu ʻana o ka hypoglycemia fetal. Wahi a ia, hoʻohana ʻia ka hoʻohana ʻana o Gliclazide i ka wā o ka hoʻoulu ʻana.

Nā ʻōkuhi a me ka dosis

Pono e hoʻonui ʻia nā papa hoʻōla a 30 mg i ka manawa i ka lā ma ka ʻaina kakahiaka. Inā loaʻa ka mea maʻi i kēia hoʻomanawanui no ka manawa mua, pono ke kau mua ka nui o 30 mg, pili pū kēia i nā poʻe ʻoi aku he 65 mau makahiki. E hoʻololi mālie i ka hopena a hiki i ka hopena therapeutic kūpono.

Ke koho ʻia nei ka koho o ka hāmeʻa ma muli o ke kau o ke kō i loko o ke kahawai ma hope o ka hoʻomaka ʻana o ka mālama ʻana. ʻO kahi loli hoʻololi hou aʻe hiki ke mālama wale ʻia ma hope o hoʻokahi pule ʻelua pule.

Hiki ke hoʻololi ʻia ka Glyclazide MB me nā papa Glyclazide me ka hoʻokuʻu ʻana (80 mg) i kahi lā i kēlā me kēia lā o nā ʻāpana he 1-4. Inā no kekahi kumu i hala ka mea maʻi i ka lāʻau lapaʻau, ʻaʻole pono e kiʻekiʻe aʻe ka hopena hou aʻe.

Inā hoʻohana ʻia nā papa ʻōlelo Glyclazide MB 30 mg e hoʻololi i kekahi lāʻau lapaʻau hypoglycemic hou, ʻaʻole pono kahi manawa hoʻololi i kēia hihia. He kūpono wale nō e hoʻopau i ka lawe ʻana i kēlā me kēia lā i ka lāila ma mua aʻe a i ka lā aʻe e lawe i ka Gliclazide MB.

Nui! Inā mālama ʻia ka mea maʻi me ka sulfonylureas me ka hapalua lōʻihi, e mālama pono ana i ka glucose o ka glucose i ke koko pono no 2 hebedoma.

Pono kēia e pale i ka hoʻomohala ʻana o ka hypoglycemia, ʻike ʻia e kū'ē i ke kāʻei o nā hopena i koe o ka hopena o ka lāʻau ma mua.

Hiki ke hoʻohui ʻia ka lāʻau lapaʻau me nā mea paʻa alpha-glucosidase, biguanides a i ʻole insulin. ʻO nā mea maʻi me ka hina ʻole a me ke kaulike ʻole o ka renal, i ʻōlelo ʻia ʻo Gliclazide MB i nā papa like ʻole e like me nā mea maʻi me ka hana ʻoi aku ka maikaʻi. Hoʻokomo ʻia ka lāʻau lapaʻau i loko o ka hana ʻoi kino.

ʻO ka poʻe maʻi i ka pilikia no ka hypoglycemia

Hoʻokomo ka poʻe maʻi i ka hoʻomohala ʻana i ka hypoglycemia:

1. kūleʻa a ʻōkuhi ʻole paha,
2. me ka hōʻemi a ʻole nā ​​maʻi endocrine koʻikoʻi (hypothyroidism, adrenal and pituitary insufficiency),
3. me ka hoʻopau ʻana o nā mea hana hypoglycemic ma hope o ko lākou hoʻohana ʻana i ka lōʻihi.
4. me nā ʻano weliweli o nā pathologies cardiovascular (maʻamau atherosclerosis, carotid arteriosclerosis, maʻi maʻi coronary),

No kēlā mau mea maʻi, ua kuhikuhi ʻia ka lāʻau lapaʻau ʻo Glyclazide MB ma nā palena liʻiliʻi (30 mg).

Nā hopena hopena

Hiki i ka lāʻau lapaʻau ke hōʻeha i ka glycemia, ka mea i hōʻike ʻia e nā ʻano kuhi penei:

• pololi
• luhi, nāwaliwali ikaika,
• hōʻeha, hōʻeha,
• hoʻonui nui loa, nāʻaihua, paresis,
• arrhythmia, palpitations, bradycardia,
• koko koko kiʻekiʻe
• pauwe, keokeo,
• huhū, hopohopo, hoʻonāukiuki, hoʻomāʻeha,
• hoʻomohala
• lēʻo ke kauā,
• ka lohi a me ka hiki ʻole ke hoʻokō i,
• nā hopena naʻau
• ʻike maka
• aphasia
• ka nalowale ʻana o ke kāohi ponoʻī
• ka manaʻo o ka hemahema ʻole
• puʻu papaʻu
• nahoa
• delirium
• ka nalowale o ka ike, coma.

1. erythema
2. ʻili ka ʻili
3. urticaria
4. ʻeha o ka ʻili.

Aia nā hewa ʻaoʻao mai ka digestive tract:

• ʻeha ka ʻōpū
• nā mea pani kūlohelohe
• paila, mamaila,
• ka maʻi hepatitis jaundice cholestatic, akā koi lākou e hoʻihoʻi koke i ka lāʻau.

ʻO ka overdose a me ke kamaʻilio

Me ka nele o ka dosage, ʻo ka hiki ke hoʻomohala ʻana i ke ʻano hypoglycemic pilikia, ka mea i hui pū ʻia e nā pilikia neurological, convulsions, coma, kiʻekiʻe. I ka ʻike mua ʻana o kēia mau hōʻailona, ​​pono ka mea maʻi i ka hoʻokipa maʻalahi.

Inā kānalua a hopuia paha kahi comog hypoglycemic, e hoʻokō ʻia ana kahi hopena 40-50% dextrose i loko o ka mea maʻi. Ma hope o kēlā, kau lākou i kahi mea pāhaʻi me kahi hopena o 5% dextrose, pono e mālama i kahi kaona o ka glucose i loko o ke koko.

Ma hope o ka hoʻomanawanui hou ʻana o ka mea maʻi, i mea e pale ʻole ai i ka hypoglycemia hou, pono ia e hāʻawi i ka ʻai i nā mea momona e hiki ke hoʻēmi ʻia. Hoʻopelena ʻia kēia e ka mākaʻikaʻi ʻana i nā pae koko koko a me ka mālama mau ʻana i ka mea maʻi i nā hola 48 e hiki mai ana.

ʻO nā hana hou aʻe, ma muli o ke ʻano o ka mea maʻi, e hoʻoholo ʻia e ke kauka komo. Ma muli o ka hoʻopili ʻia ʻana o ka lāʻau i nā protein plasma, hiki ʻole i ka dialysis ka maikaʻi.

Hoʻonui ʻo Glyclazide i ka hopena o nā anticoagulants (warfarin), ʻo ke kūlana wale nō e pono ai ʻoe e hoʻoponopono hou i nā ʻano o nā anticoagulant.

ʻO Danazole me Gliclazide kahi hopena maʻi maʻi. ʻOiai i ka wā o ka hoʻohana kālā o ka danazol a ma hope o kona hoʻoneʻe ʻia, pono ʻia ka hoʻomalu ʻana o ka glucose a me ke hoʻoponopono ʻana o Glyclazide.

Hoʻonui ka systemic i ka phenylbutazone e hoʻonui i ka hopena hypoglycemic of Gliclazide (e hoʻolei ana i ka excretion mai ke kino, ka haʻalele ʻana i ka kamaʻilio me nā ʻōnaehana koko). Pono ʻia ka nānā ʻana o ka maʻi glyclazide a me ka nānā ʻana i ke koko glucose. ʻO nā manawa ʻelua e lawe ai i ka phenylbutazone, a ma hope o ka haʻalele ʻana.

Me ka hoʻonohonoho ʻōnaehana o Miconazole a i ka wā e hoʻohana ai i ka gel i ka puʻupuʻu waha, e hoʻomaikaʻi ana i ka hopena hypoglycemic o ka lāʻau lapaʻau, a hiki i ka hoʻomohala ʻana i ka piko.

Hoʻonui ka Ethanol a me kāna mau mea i ka hypoglycemia, hiki ke alakaʻi i ka hoʻomohala ʻana o ka coma hypoglycemic.

I ka manawa e hui pū me nā lāʻau lapaʻau hypoglycemic ʻē aʻe (biguanides, acarbose, insulin), fluconazole, beta-blockers, H2-histamine receptor blockers (cimetidine), angiotensin-hoʻohuli i ka hoʻōla o ka enzyme (enalapril, antioxidant captoprilamide, non-steroidal sulfide inhibitors a ka hopena o ka hypoglycemic, ma ka hopena o ka hōʻeha o ka hypoglycemia.

ʻO Chlorpromazine i loko o nā wai he nui (ʻoi aku ma mua o 100 mg / lā) e hoʻonui i ka kaila o ka glucose i ke koko, me ka pale ʻana i ka huna ʻana o ka insulin. Ke aʻo ʻia nei i ka wā o ka hoʻohana ʻana o ka chlorpromazine a ma hope o kona hoʻoneʻe ʻana, pono ka ʻike glucose a me ka hoʻololi o ke ʻano lāʻau o Gliclazide.

Hoʻonui ka GCS (rectal, external, intraarticular, hoʻohana i ka ʻōnaehana) hoʻonui i ke kō koko koko me ka hiki ke hoʻomau i ka ketoacidosis. ʻOiai i ka wā o ka hoʻohana ʻana o GCS a ma hope o ko lākou haʻalele ʻana, pono ka mana glucose a me ke hoʻololi ʻana i ka hopena o Gliclazide e pono ai.

Terbutaline salbutamol, erythrocytes intravenous - hoʻonui i ke kōhi koko. Manaʻo ʻia o ka glucose i ke kahe koko a inā pono, inā pono, he hoʻololi no ka lāʻau lapaʻau i ka insulin.

Nā ʻōlelo kūikawā a me ka puka hoʻokuʻu

Hoʻohana wale ʻia ka lāʻau Gliclazide MB i ka hui pū ʻana me ka meaʻai haʻahaʻa haʻahaʻa, ʻo ia ka mea liʻiliʻi o nā kālaiʻai. Pono ʻia ka mālama ʻana i ka hoʻoliʻiliʻi o ka glucose, ma ka ʻōpū ʻole a ma hope o ka ʻaina, pono ʻia. He mea koʻikoʻi kēia i ka hoʻomaka mua o ka mālama ʻana.

I ka wā o ka mālama ʻana me ka lāʻau lapaʻau, i mea e pale aku ai i nā hōʻeha a me nā mea i hōʻeha ma ke ala, ʻo ka mea ia e pale aku i ka hoʻokele ʻana i nā kaʻa a me ka hana ʻana me nā kīʻaha pōʻino e koi ai i ka manaʻo o ke koʻikoʻi a me ka wikiwiki o ka hopena.

Nā papale 30 mg, waiho ʻia i nā pōpō o 10 mau ʻāpana.

ʻO 3 mau makahiki kahi e noho ai ke ola o Gliclazide, a laila ʻaʻole hiki ke hoʻohana ʻia. Pono ke mālama i ka lāʻau lapaʻau i kahi maloʻo a uliuli loa a hiki ʻole ke mālama ʻia i nā keiki.

I nā wahi ʻokoʻa o ka ʻāina, e like paha ke kumukūʻai o ka lāʻau lapaʻau mai 120 a 150 mau rubles. Ke kamaʻilio nei mākou e pili ana i nā paʻi pili 60 mau papa. Aia i ka mākaʻi i nā kaha polū. Hoʻokomo hoʻokahi pahu a iʻole 1 i 6 mau lula paha i loko o kahi pahu pepa.

Ka ʻokoʻa o ka uku i kau ʻia i nā mea like ʻole: ka mea hana, ka ʻāina, ke kūlana o ka lāʻau lapaʻau.

Ke ʻano o ka noi

No ka lawelawe waha. Ka lāʻau Hoʻolaha iā Gliclazide MV i manaʻo ʻia no ka hana pākeke wale nō.
Hiki i ka maʻi maʻamau o kēlā me kēia lā ʻo MV Glyclazide mai 30 mg a 120 mg. Hoʻonohonoho ʻia e lawe i ka manawa 1 i ka lā i ka wā o ka kakahiaka kakahiaka, e ʻoki i nā papa āpau me ka ʻoka ʻole.
Inā kānalua ʻoe i ka lāʻau lapaʻau, ʻaʻole hiki iā ʻoe ke hoʻonui i ka ʻāpopo i ke lā aʻe.!
E like me nā lāʻau lapaʻau hypoglycemic ʻē aʻe, pono ke koho pono ʻia ka nui o kēia lāʻau i kēlā me kēia hihia, i ka hopena o ka metabolic o ka mea maʻi.
ʻO ka ʻōmua i ʻōlelo mua ʻia he 30 mg (1 papa o Gliclazda MV me kahi waihona o 30 mg a i ʻole 1 papa papa me kahi maʻi o 60 mg).
I ka hihia o ka mālama pono o ka nui o ka glucose o ke koko, hiki ke hoʻohana ʻia kēia lāʻau ma ke ʻano he mālama mālama.
Ināʻaʻa ʻaʻole pono ka nui o ka pae o ka glucose, hiki ke piʻi ikaika ka nui ma kahi o 60 mg, 90 mg a 120 mg i kēlā me kēia lā. ʻO ka manawa ma waena o ka hoʻonui mauʻana i ka hopena o ka lāʻau e pono ma kahi o ka mahina e 1 mau mahina, ke ʻole e emi ka pae ʻana o ke koko ma hope o nā hebedoma ʻelua o ka lapaʻau. I kēlā mau kūlana, hiki ke hoʻonui ʻia ke ʻano i ʻelua mau pule ma hope o ka hoʻomaka ʻana o ka mālama ʻana.
ʻO ka dosis kiʻekiʻe loa i ʻōlelo ʻia i kēlā me kēia lā he 120 mg.
ʻO kahi 60 mg Glyclazide MV hoʻololi kāpae e hoʻohālikelike ʻia me nā ʻelua 30 mg Gliclazide MV hoʻololi i papa papa. He maʻalahi ka hoʻokaʻawale ʻana o ke Glyclazide MV 60 mg tablet-hoʻokaʻawale, e hiki ai ke hoʻololi ʻia ke ʻano o ka lāʻau lapaʻau.
Hoʻohana me ka hui pū me nā lāʻau lapaʻau antidiabetic
Hiki ke hoʻohana i ka Gliclazide MB i ka hui pū me ka biguanidines, nā alpha-glucosidase inhibitors a i ʻole insulin. No ka poʻe maʻi e ʻike ʻole ʻia ka nui o ka glucose koko ma ka lawe ʻana i ka Gliclazide MV, hiki ke kuhikuhi ʻia ka lāʻau lapaʻau ma lalo o ka mākaʻi loea olakino.
Poʻe kānaka
ʻO nā moʻo i ʻōlelo ʻia no nā ʻelemakule e like nō ia me nā mea pākeke ma lalo o ka 65 makahiki o kona mau makahiki.
ʻO Renal hiki ʻole
ʻO nā ʻōnaʻi o ka lāʻau no ka hiki ʻole o ke kīleʻa i ke kaumaha me ka hōʻino ʻana i ke ʻano o ka hōʻeha ʻokoʻa i nā poʻe no ka poʻe me ka hana maʻamau.
ʻO ka maʻi me ka nui o ka puʻu o ka hypoglycemia: me ka pōʻino, me ka hōʻemi a me ka hoʻopiʻi ʻole ʻana i ka hopena endocrine (hypopituitarism, hypothyroidism, adrenocorticotropic hormone deficiency).
-pai hiki ke hoʻopau ʻia ʻana o ka maʻi corticosteroid ma mua, a i ʻole ke kiʻekiʻe o ka maʻi corticosteroid, i nā maʻi maʻi vascular (maʻi ʻeha coronary koʻikoʻi, pilikia hōʻoki o ka carotid artery, hoʻopili aku i nā maʻi vascular).
Ke aʻoaʻo ʻia nei e kuhikuhi i ka lāʻau lapaʻau me ka liʻiliʻi haʻahaʻa o kēlā me kēia lā no 30 mg.

ʻElua hopena:
Hoʻomaʻamaʻa Glyclazide MV hiki ke alakaʻi i ka hypoglycemia i nā hihia o kaʻai ʻana i ka meaʻai aʻai a keu hoʻi i nā hihia o ke kaʻina.
Nā hōʻailona hōʻailona paha o ka hypoglycemia: ʻeha, ka pōloli, ke kaumaha, ka luaʻi, ka luhi, ka hoʻomaha moe, ka hoʻomākeʻaka, ka luhi, ka hopohopo poʻohiwi o ka nānā, hoʻemi i ka hiki ke loiloi i ke kūlana a lohi, hōʻeha, pōpilikia, ʻike a me ka maʻi hilahila, aphasia, haʻalulu , ka paresis, ka hoʻohaʻahaʻa i ka naʻau, dizziness, ka manaʻo o ka kōkua ʻole, ka nalowale o ka mālama ʻana i ka koe, ke kūlana delusional, nā kīwaha, ka lau pāpio, bradycardia, ke hiamoe a me ka nalowale o ka ʻike, nā mea e hopena ai holoi a hōʻeha paha.

Eia kekahi, pono paha nā hōʻailona o ka adrenergic counter-regulation, e like me ka lula, ka pipi clammy, ka hopohopo, tachycardia, ke koko kiʻekiʻe, ka nui o ka naʻau, ka angina pectoris a me ka arrhythmia cardiac.
Kuhi pinepine kēia mau hōʻailona ma hope o ka lawe ʻana i ka ʻai (sugar). I ka manawa like, ʻaʻohe hopena o nā mea aloha kūlohelohe i kēia hopena.
Ma ka hōʻeha a me ka hoʻoulu ʻia ʻana o ka hypoglycemia, ʻoiai hiki ke hoʻopau ʻia i ka manawa pōkole me ke kō, hiki koke ke hoʻolako i ka mālama lapaʻau a i ʻole, inā pono, e hoʻokau i ka mea maʻi.
Nā hopena ʻē aʻe i makemake ʻia:
nā hana hōʻeha o ka ʻōnaehana gastrointestinal (hōʻeha, ka maʻi maʻi, ka ʻeha o ka ʻeha i loko o ka ʻōpū, constipation, ʻeha o ka ʻōpū, ka luaʻi, ka luaʻi). ʻOi aku ka liʻiliʻi o kēia mau maʻi me ka koho ʻana o Gliclazide MV i ka wā kakahiaka.
Nā hopena pili laha:
nā huakiko: kala, urticaria, maculopapular rash,
mai ka hematopoietic a me nā limahana lymphatic: nā hoʻololi hematological. ʻO kēia paha ka anemia, leukopenia, thrombocytopenia, granulocytopenia. ʻO ka maʻamau, nalowale kēia mau hōʻailona ma hope o ke hoʻōki ʻana i ka lāʻau.
nā hana o ke kūpaʻa a me nā ʻāpana polū: hoʻonui i ka hana o nā enzymes "ate" (aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase), hepatitis (mau hihia).Inā hele mai ka jaundice cholestatic, pono e hoʻokuʻu ʻia ka lāʻau lapaʻau. ʻO ka maʻamau, nalowale kēia mau hōʻailona ma hope o ke hoʻōki ʻana i ka lāʻau.
kahi maʻi moho.

Hoʻopili pū me nā lāʻau ʻē aʻe

I kekahi manawa pono e hoʻoponopono i ka pona o kahi papa antidiabetic i ka wā a ma hope o ka hoʻomau danazol.
Pono paha e hoʻoponopono i ka hopena o ka lāʻau antidiabetic i ka manawa a ma hope o ka hoʻokō ʻana o ka mālama kālāzol.
ʻO nā hui e koi ana i nā pākuʻi kūikawā.
ʻO Chlorpromazine: i nā koina kiʻekiʻe (ma mua o 100 mg o ka lā) e hoʻonui i ka glucose o ke koko, e hoʻemi ana i ka mea huna o ka insulin.
ʻO Glucocorticosteroids (ka ʻōnaehana a me ka topical: intraarticular, ka ʻili a me ka hoʻoponopono rectal) a me tetracosactrin e hoʻonui i nā pae glucose o ke koko me ka hiki ke hoʻomohala i ka ketoacidosis (hoʻemi i ka hoʻohaʻahaʻa kalepa e nā glucocorticosteroids).
Progestogens: ʻO ka hopena o ka maʻi maʻi o nā progestogens kiʻekiʻe. β-2-adrenostimulants - ritodrin, salbutamol, terbutaline: (lawelawe systemic): nui pae.
E makaʻala pono i ka mea nui o ka mālama ponoʻina ʻana o ka glucose koko. Inā pono, e hoʻokaʻawale i ka mea maʻi i ka therapy insulin.
Inā pono ʻoe e hoʻohana i nā hoʻohui ma luna, pono e mālama pono i ka mālama ʻana i nā pae glucose koko. He mea pono paha ia e hoʻoponopono hou i ka hapa o MV Glyclazide ʻelua i ka wā hui pū ʻana a ma hope o ka hoʻokuʻu ʻana o ka lāʻau lapaʻau hou.
ʻO nā hui e noʻonoʻo.
ʻO ka wehe ʻana i nā hoʻomākaukau anticoagulant (warfarin): ka hoʻokipa ʻana o nā derivatives sulfonylurea hiki ke hoʻonui i ka hopena anticoagulant o ia hoʻomākaukau. Hiki ke koi ʻia ka hoʻoponopono ʻo Anticoagulant.

Hoʻokomo i ka hiki ke alakaʻi i nā kaʻa a kāohi i nā ʻonanekona:
ʻO nā mea maʻi e lawe nei Luna Hue makaʻala i nā ʻike o ka hypoglycemia a hoʻohana i ka mālama ʻana i ka wā e hoʻokele a hana ana i nā hana e koi ana i ke kiʻekiʻe o ka hopena o ke kino a me ka noʻonoʻo.

Nā kūlana mālama

Ma kahi wahi i pale ʻia ai ka lepo a me ka mālamalama ma kahi mahana o ʻaʻole kiʻekiʻe aʻe ma mua o 25 ° C.
Mai mālama i nā keiki.

Ka lā hiki:
No kahi pākēneka o 30 mg, ʻoi ka ola o ka papa.
No kahi pākana o 60 mg, ʻo ke ola o ka noho papa no 2 mau makahiki.
Mai hoʻohana ma hope o ka lā pau pau i hōʻike ʻia ma ka pahu.

E hoʻokuʻu i ke ʻano

Ka lāʻau Hoʻolaha iā Gliclazide MV hoʻopuka i ka palapala t kaHoʻopaʻa hou ʻia
ʻO nā papa pōʻai o ke keʻokeʻo a i ʻole keʻokeʻo paha ke keʻokeʻo me kahi ʻano cylindrical me kahi bevel (dosage o 30 mg).
ʻO nā papa pōʻai o ke keʻokeʻo a i ʻole keʻokeʻo paha ke aniani me kahi ʻano cylindrical me kahi chamfer a me kahi ikehu (dosage o 60 mg).
10 papa i nā pōpō palula. ʻEkolu a ʻeono paha i nā kīlei palepona, a me nā ʻōlelo no ka hoʻohana ʻana i kahi kāʻele pepa.